Европейский союз - румынский - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - alte preparate antianemice - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.

Европейский союз - румынский - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - preparate antianemice - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Европейский союз - румынский - EMA (European Medicines Agency)

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - preparate antianemice - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Европейский союз - румынский - EMA (European Medicines Agency)

theravia - hidroxicarbamida - anemie, sickle cell - agenți antineoplazici - siklos este indicat pentru prevenirea infectiilor recurente dureroase crize vaso-ocluzive inclusiv sindromul toracic acut la pacienții copii și adulți care suferă de simptomatic sickle-cell sindromul.

Европейский союз - румынский - EMA (European Medicines Agency)

nova laboratories ireland limited - hidroxicarbamida - anemie, sickle cell - agenți antineoplazici - prevenirea vaso-ocluzive complicații de secera de celule bolii la pacienții cu vârsta peste 2 ani.

Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

boiron - franta - homeopate - sirop - homeopate cu indicatii terapeutice homeopate cu indicatii terapeutice

Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

boiron - franta - homeopate - unguent - homeopate cu indicatii terapeutice homeopate cu indicatii terapeutice

Европейский союз - румынский - EMA (European Medicines Agency)

virbac s.a. - recombinant omega interferon de origine felină - imunostimulante, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. la pisicile infectate cu fiv, mortalitatea a fost scăzută (5%) și nu a fost influențată de tratament.

Молдова - румынский - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

sperco-ucraina im - o combinatie - capsule

Европейский союз - румынский - EMA (European Medicines Agency)

merck sharp dohme ltd - boceprevir - hepatita c, cronică - antivirale pentru uz sistemic - victrelis este indicat pentru tratamentul hepatitei c cronice (chc) genotip-1 infecţie, în asociere cu interferon alfa şi ribavirină, la pacienţii adulţi cu boli hepatice compensate care sunt netratat anterior sau care au eşuat anterioare terapie.